AMNOG and the German Reforms: What Will Change?

By Preeti Patel and Sophie Schmitz on Oct 3, 2016 ¬†We analyze recent changes in Germany’s pharmaceutical legislation & implications for the industry. Germany is typically prioritized by the pharmaceutical industry: it remains a market with relatively high drug prices, offers extensive commercial opportunities and has an important position as an international reference country to … More AMNOG and the German Reforms: What Will Change?